PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) WITH HD- MTX BASED CHEMOTHERAPY: TOLERABILITY AND RESULTS

被引：0
|
作者：
Silvani, A. [1 ]
Anghileri, E. [1 ]
Simonetti, G. [1 ]
Eoli, M. [1 ]
Finocchiaro, G. [1 ]
Pollo, B. [1 ]
Farinotti, M. [1 ]
Fariselli, L. [1 ]
Gaviani, P. [1 ]
机构：
[1] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
10.1093/neuonc/noz126.299
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P14.64
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [31] Combined intra-arterial high-dose methotrexate (MTX) infusion and systemic chemotherapy for primary central nervous system malignant lymphoma (PCNSL)
    Hayashi, A
    Sato, H
    Kyuma, Y
    Nishimura, S
    Kanno, H
    Yamamoto, I
    Proceedings of the 13th World Congress of Neurological Surgery, Vols 1 and 2, 2005, : 641 - 645
  • [32] Recurrent primary central nervous system lymphoma (PCNSL) treated with pemetrexed
    Altman, J. K.
    Gallot, L.
    Cohn, R.
    Chandler, J.
    Levy, R.
    Getch, C.
    Marymont, M.
    Tellez, C.
    Raizer, J. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Systemic relapse following primary central nervous system lymphoma (PCNSL)
    Moore, DF
    Rosenfeld, MR
    Abrey, LE
    NEUROLOGY, 1998, 50 (04) : A270 - A270
  • [34] LENALIDOMIDE IN THE TREATMENT OF RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
    Houillier, C.
    Choquet, S.
    Touitou, V.
    Martin-Duverneuil, N.
    Hoang-Xuan, K.
    NEURO-ONCOLOGY, 2014, 16
  • [35] A Series of Patients with Primary Central Nervous System Lymphoma (PCNSL) and AIDS
    Eisenstein, J. E.
    Mosunjac, M. B.
    MODERN PATHOLOGY, 2010, 23 : 333A - 333A
  • [36] Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)
    Bergner, Nicole
    Monsef, Ina
    Illerhaus, Gerald
    Engert, Andreas
    Skoetz, Nicole
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (11):
  • [37] Chemotherapy of primary central nervous system lymphoma
    Delwail, V
    Bataille, B
    NEUROCHIRURGIE, 1997, 43 (06) : 380 - 384
  • [38] Incidence of occult systemic lymphoma in patients with primary central nervous system lymphoma (PCNSL)
    Shah, V.
    Dunlop, A.
    Yallop, D.
    Marcus, R.
    Devereux, S.
    Patten, P.
    Kassam, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 89 - 89
  • [39] THERAPY OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA (PCNSL) WITH METHOTREXATE (MTX)-BASED INTRAVENOUS CHEMOTHERAPY (MBISC) AND DEFERRED WHOLE-BRAIN RADIATION-THERAPY (WBRT)
    CHER, L
    GLASS, J
    HOCHBERG, FH
    NEUROLOGY, 1994, 44 (04) : A378 - A379
  • [40] Early urinary potassium level is predictive of delayed methotrexate (MTX) elimination in patients with primary central nervous system lymphoma (PCNSL)
    Bertucci, A.
    Harlay, V.
    Boucard, C.
    Petrirena, G.
    Campello, C.
    Autran, D.
    Barrie, M.
    Chinot, O.
    Tabouret, E.
    ANNALS OF ONCOLOGY, 2023, 34 : S408 - S408
12345